Cargando…

Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator: Erratum

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531042/ https://www.ncbi.nlm.nih.gov/pubmed/31083275 http://dx.doi.org/10.1097/MD.0000000000015739

Ejemplares similares

Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator
por: Liu, Shi-Ying, et al.
Publicado: (2018)

Skin intrinsic fluorescence is associated with hemoglobin A(1c) and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care 2011;34:1816–1820
por: Felipe, DL, et al.
Publicado: (2013)

Erratum: Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
Publicado: (2018)

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
por: Hong, Keun-Sik, et al.
Publicado: (2009)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
por: Matsuo, Ryu, et al.
Publicado: (2014)

Relationship between homocysteine level and prognosis of elderly patients with acute ischemic stroke treated by thrombolysis with recombinant tissue plasminogen activator
por: Li, Juan, et al.
Publicado: (2019)

Blood pressure excursion on admission and intravenous thrombolysis in ischemic stroke
por: Du, Linzhe, et al.
Publicado: (2023)

Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients
por: Wang, Zhong-Xiu, et al.
Publicado: (2020)

Erratum to: Estimation of mean systemic filling pressure in postoperative cardiac surgery patients with three methods
por: Maas, Jacinta J., et al.
Publicado: (2012)

Erratum to “A Proposed New Index for Clinical Evaluation of Interproximal Soft Tissues: The Interdental Pressure Index”
por: Checchi, Luigi, et al.
Publicado: (2014)

Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
por: Yang, Hung-Wei, et al.
Publicado: (2012)

Low dose statins improve prognosis of ischemic stroke patients with intravenous thrombolysis
por: Cui, Chaohua, et al.
Publicado: (2021)

Erratum to: Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices
por: Vicens-Zygmunt, Vanesa, et al.
Publicado: (2015)

Impact of glycosylated hemoglobin on early neurological deterioration in acute mild ischemic stroke patients treated with intravenous thrombolysis
por: Han, Lin, et al.
Publicado: (2023)

Erratum: Does the Mean Arterial Pressure Influence Mortality Rate in Patients with Acute Hypoxemic Respiratory Failure under Mechanical Ventilation?
por: Gjonbrataj, Juarda, et al.
Publicado: (2015)

Acute Antidepressant Effects of Intramuscular Versus Intravenous Ketamine: Erratum
Publicado: (2015)

Erratum to: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models
por: Chen, Jin-Shuen, et al.
Publicado: (2017)

Long-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic Stroke
por: Lee, Bo-Yeon, et al.
Publicado: (2019)

Erratum to: Decontamination of dental implant surfaces by means of photodynamic therapy
por: Marotti, Juliana, et al.
Publicado: (2013)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

Correlation of Pretreatment Hemoglobin and Platelet Counts with Clinicopathological Features in Colorectal Cancer in Saudi Population: Erratum
Publicado: (2015)

Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
por: Doepp, Florian, et al.
Publicado: (2005)

Erratum: Group A Streptococcus exploits human plasminogen for bacterial translocation across epithelial barrier via tricellular tight junctions
por: Sumitomo, Tomoko, et al.
Publicado: (2017)

Erratum: Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2015)

Erratum to: Integrating mean and variance heterogeneities to identify differentially expressed genes
por: Ouyang, Weiwei, et al.
Publicado: (2017)

The Clinical Value of Systemic Inflammatory Response Index and Inflammatory Prognosis Index in Predicting 3-Month Outcome in Acute Ischemic Stroke Patients with Intravenous Thrombolysis
por: Ma, Xin, et al.
Publicado: (2022)

Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018)

Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)

Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke
por: He, Yao‐De, et al.
Publicado: (2020)

Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study
por: Zengin, Emine, et al.
Publicado: (2021)

Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Zhou, Hongyu, et al.
Publicado: (2020)

Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society
por: TOYODA, Kazunori, et al.
Publicado: (2019)

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)
por: Liu, Yunzhu, et al.
Publicado: (2022)

The white blood cell count to mean platelet volume ratio for ischemic stroke patients after intravenous thrombolysis
por: Weng, Yiyun, et al.
Publicado: (2022)

Middle Cerebral Artery Calcification: Association With Ischemic Stroke: Erratum
Publicado: (2016)

Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke
por: Hasumi, Keiji, et al.
Publicado: (2021)

Skin Intrinsic Fluorescence Is Associated With Hemoglobin A(1c) and Hemoglobin Glycation Index but Not Mean Blood Glucose in Children With Type 1 Diabetes
por: Felipe, Dania L., et al.
Publicado: (2011)

Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome
por: Shaw, Andrew D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ppu2e351oqoec8n2m8keask8gs